183 related articles for article (PubMed ID: 33932609)
1. Profibrotic mechanisms of DPP8 and DPP9 highly expressed in the proximal renal tubule epithelial cells.
Zhang Y; Li K; Li Y; Zhao W; Wang L; Chen Z; Ma X; Yao T; Wang J; Dong W; Li X; Tian X; Fu R
Pharmacol Res; 2021 Jul; 169():105630. PubMed ID: 33932609
[TBL] [Abstract][Full Text] [Related]
2. DPP8/9 inhibition attenuates the TGF-β1-induced excessive deposition of extracellular matrix (ECM) in human mesangial cells via Smad and Akt signaling pathways.
Li K; Zhang Y; Zhao W; Wang R; Li Y; Wei L; Wang L; Chen X; Chen Z; Liu P; Nie N; Tian X; Fu R
Toxicol Lett; 2024 May; 395():1-10. PubMed ID: 38458339
[TBL] [Abstract][Full Text] [Related]
3. Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.
Chowdhury S; Chen Y; Yao TW; Ajami K; Wang XM; Popov Y; Schuppan D; Bertolino P; McCaughan GW; Yu DM; Gorrell MD
World J Gastroenterol; 2013 May; 19(19):2883-93. PubMed ID: 23704821
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a dipeptidyl peptidases (DPP) 8/9 expressing cell model for evaluating the selectivity of DPP4 inhibitors.
Huan Y; Jiang Q; Liu JL; Shen ZF
J Pharmacol Toxicol Methods; 2015; 71():8-12. PubMed ID: 25464020
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical role of the dipeptidyl peptidases DPP8 and DPP9 in ovarian carcinoma.
Brunetti M; Holth A; Panagopoulos I; Staff AC; Micci F; Davidson B
Virchows Arch; 2019 Feb; 474(2):177-185. PubMed ID: 30467600
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies on isoindoline inhibitors of dipeptidyl peptidases 8 and 9 (DPP8, DPP9): is DPP8-selectivity an attainable goal?
Van Goethem S; Matheeussen V; Joossens J; Lambeir AM; Chen X; De Meester I; Haemers A; Augustyns K; Van der Veken P
J Med Chem; 2011 Aug; 54(16):5737-46. PubMed ID: 21711053
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated P311 ameliorates renal fibrosis through inhibition of epithelial-mesenchymal transition via TGF-β1-Smad-ILK pathway in unilateral ureteral obstruction rats.
Qi FH; Cai PP; Liu X; Si GM
Int J Mol Med; 2018 May; 41(5):3015-3023. PubMed ID: 29436600
[TBL] [Abstract][Full Text] [Related]
8. DPP8 and DPP9 expression in cynomolgus monkey and Sprague Dawley rat tissues.
Harstad EB; Rosenblum JS; Gorrell MD; Achanzar WE; Minimo L; Wu J; Rosini-Marthaler L; Gullo R; Ordway ND; Kirby MS; Chadwick KD; Cosma GN; Moyer CF
Regul Pept; 2013 Sep; 186():26-35. PubMed ID: 23850796
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis.
Matheeussen V; Waumans Y; Martinet W; Van Goethem S; Van der Veken P; Scharpé S; Augustyns K; De Meyer GR; De Meester I
Basic Res Cardiol; 2013 May; 108(3):350. PubMed ID: 23608773
[TBL] [Abstract][Full Text] [Related]
10. The amino-dipeptidyl peptidases DPP8 and DPP9: Purification and enzymatic assays.
Donzelli L; Bolgi O; Geiss-Friedlander R
Methods Enzymol; 2023; 684():289-323. PubMed ID: 37230592
[TBL] [Abstract][Full Text] [Related]
11. MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2.
Tang H; Fan D; Lei CT; Ye C; Gao P; Chen S; Meng XF; Su H; Zhang C
J Mol Med (Berl); 2016 Nov; 94(11):1297-1307. PubMed ID: 27488450
[TBL] [Abstract][Full Text] [Related]
12. The SUMO1-E67 interacting loop peptide is an allosteric inhibitor of the dipeptidyl peptidases 8 and 9.
Pilla E; Kilisch M; Lenz C; Urlaub H; Geiss-Friedlander R
J Biol Chem; 2013 Nov; 288(45):32787-32796. PubMed ID: 24072711
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase 9 (DPP9) in human skin cells.
Gabrilovac J; Čupić B; Zapletal E; Kraus O; Jakić-Razumović J
Immunobiology; 2017 Feb; 222(2):327-342. PubMed ID: 27682012
[TBL] [Abstract][Full Text] [Related]
14. Shenqi detoxification granule combined with P311 inhibits epithelial-mesenchymal transition in renal fibrosis via TGF-β1-Smad-ILK pathway.
Cai P; Liu X; Xu Y; Qi F; Si G
Biosci Trends; 2017; 11(6):640-650. PubMed ID: 29311449
[TBL] [Abstract][Full Text] [Related]
15. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
16. A novel role of dipeptidyl peptidase 9 in epidermal growth factor signaling.
Yao TW; Kim WS; Yu DM; Sharbeen G; McCaughan GW; Choi KY; Xia P; Gorrell MD
Mol Cancer Res; 2011 Jul; 9(7):948-59. PubMed ID: 21622624
[TBL] [Abstract][Full Text] [Related]
17. CUX1 promotes epithelial-mesenchymal transition (EMT) in renal fibrosis of UUO model by targeting MMP7.
Teng S; Liu G; Li L; Ou J; Yu Y
Biochem Biophys Res Commun; 2022 Jun; 608():128-134. PubMed ID: 35397425
[TBL] [Abstract][Full Text] [Related]
18. DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages.
de Vasconcelos NM; Vliegen G; Gonçalves A; De Hert E; Martín-Pérez R; Van Opdenbosch N; Jallapally A; Geiss-Friedlander R; Lambeir AM; Augustyns K; Van Der Veken P; De Meester I; Lamkanfi M
Life Sci Alliance; 2019 Feb; 2(1):. PubMed ID: 30718379
[TBL] [Abstract][Full Text] [Related]
19. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl peptidase 8/9-like activity in human leukocytes.
Maes MB; Dubois V; Brandt I; Lambeir AM; Van der Veken P; Augustyns K; Cheng JD; Chen X; Scharpé S; De Meester I
J Leukoc Biol; 2007 May; 81(5):1252-7. PubMed ID: 17287297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]